Is Moderna (MRNA) Quietly Redefining Its Pipeline With Canada’s Bundibugyo Ebola Trial Green Light?
Moderna CEO Stephane Bancel disposes of 499,246 shares for $9.56 million
Moderna mRNA flu shot wins FDA approval but awaits CDC recommendations
These new drugs could fuel fresh highs for biotech and pharma stocks
Stocks Move Mixed as Dow Reverses Premarket Gains
Moderna Stock (MRNA) Gains on U.S. Approval for New Flu Shot Type — Why This Matters